In contrast to IFN-γ production, the capacity of NK cells to upregulate CD107a in response to U937 cell-induced activation was not reduced in untreated AML patients, but was rather somewhat increased in patients after chemotherapy when compared to healthy controls. This evidence concerns the gene LAMP1 and acute myeloid leukemia.